AMSBIO has announced the opening of a new North American headquarters with executive management facilities in Cambridge, MA** for its US subsidiary - AMSBIO LLC. Commenting on this strategic move, Alex Sim said "The US is the single largest market for our stem cell and regenerative medicine, glycobiology enzymes / substrates and tissue derived ... (more)
http://ift.tt/QKLCuP
http://ift.tt/QKLCuP
No comments:
Post a Comment